DUBLIN, Dec. 17,
2024 /PRNewswire/ -- Jazz Pharmaceuticals plc
(Nasdaq: JAZZ) today announced that the Company will webcast its
corporate presentation at the 43rd Annual J.P. Morgan
Healthcare Conference. Bruce Cozadd,
chairman and chief executive officer, will provide an overview of
the company and a business update on Tuesday, January 14, 2025, at 9:45 a.m. PST / 5:45 p.m.
GMT.
A live audio webcast of the presentation may be accessed via the
Investors section of the Jazz Pharmaceuticals website at
https://investor.jazzpharma.com/investors/events-presentations. A
replay of the webcast will be available on the website for 30 days
following the conference.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc
(Nasdaq: JAZZ) is a global biopharma company whose purpose is to
innovate to transform the lives of patients and their families. We
are dedicated to developing potentially life-changing medicines for
people with serious diseases — often with limited or no therapeutic
options. We have a diverse portfolio of marketed medicines,
including leading therapies for sleep disorders and epilepsy, and a
growing portfolio of cancer treatments. Our patient-focused and
science-driven approach powers pioneering research and development
advancements across our robust pipeline of innovative therapeutics
in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development
laboratories, manufacturing facilities and employees in multiple
countries committed to serving patients worldwide. Please visit
www.jazzpharmaceuticals.com for more information.
Contacts:
Investors:
Jeff Macdonald
Executive Director, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Ireland, +353 1 634 3211
U.S., +1 650 496 2717
Media:
Kristin
Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland, +353 1 637 2141
U.S., +1 215 867 4948
Logo -
https://mma.prnewswire.com/media/272253/Jazz_Pharmaceuticals_New_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/jazz-pharmaceuticals-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302334239.html
